O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$139M
2
+$132M
3
+$110M
4
PFE icon
Pfizer
PFE
+$98.3M
5
GILD icon
Gilead Sciences
GILD
+$85.6M

Top Sells

1
+$372M
2
+$99.8M
3
+$98.1M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$68M

Sector Composition

1 Healthcare 97.58%
2 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
126
$1.33M 0.02%
350,000
127
$1.24M 0.02%
176,851
128
$1.07M 0.02%
104,800
129
$1.06M 0.02%
+17,310
130
$1.05M 0.02%
133,000
131
$956K 0.02%
67,918
132
$852K 0.01%
92,211
+23,794
133
$812K 0.01%
+68,553
134
$675K 0.01%
336
135
$472K 0.01%
66,909
-124,300
136
$184K ﹤0.01%
+7,400
137
$142K ﹤0.01%
71,994
-278,706
138
$92K ﹤0.01%
1,731
139
– –
-715,100
140
– –
-96,143
141
– –
-12,480
142
– –
-1,012,800
143
– –
-69,600
144
– –
-720,679
145
– –
-106,600
146
– –
-59,500
147
– –
-59,000
148
– –
-106,900
149
– –
-41,460
150
– –
-994,808
3 4 5
6
7